6G Controls - Leading Supplier of New & Original PLC 、DCS Parts and Automation Controller
Introduction:
Yokogawa Electric Corporation has introduced the CellVoyager CQ3000, a cutting-edge high-content analysis system designed to capture high-definition 3D microscopic images of live cell cultures. Scheduled for commercial release later in 2024, the CQ3000 expands Yokogawa’s CellVoyager product range, offering advanced imaging capabilities for a variety of research applications, from basic science to drug discovery screening.
Key Features of CQ3000:
The CQ3000 is engineered for high-definition observation of live cell cultures over extended periods. Equipped with Yokogawa’s precision temperature control and a dual spinning-disk with microlens, the system captures optical slice images at high speed and superior sensitivity, minimizing cell damage compared to other confocal systems in the market. This feature ensures stable and precise observation, crucial for a range of biological and medical studies.
High-Speed Screening and Imaging:
With enhanced stage control and auto-focus functions, the CQ3000 enables high-speed screening by capturing images of microplates rapidly. The optional dual camera and wide-field image capture feature further reduce image capture time, facilitating the swift selection of potential chemical compounds from extensive lists of new drug candidates. This speed and efficiency are pivotal in expediting drug discovery processes.
High Image Quality and Versatility:
Yokogawa‘s proprietary water immersion lens mechanism ensures not only detailed observation at high magnification but also bright images at low magnification levels. The optional uniformizer enhances even illumination across the entire field of view, resulting in vivid images. This versatility allows researchers to explore a broad spectrum of cellular reactions and assess the impact of drug compounds efficiently.
Professional Insight:
As a professional in the field, I find the CQ3000’s introduction to be a significant step forward in live cell imaging technology. The system’s emphasis on high-speed screening and high image quality, coupled with its versatile applications, positions it as a valuable tool for researchers engaged in diverse biological and medical studies. The integration of advanced features, such as dual spinning-disk with microlens and water immersion lens mechanism, underscores Yokogawa’s commitment to advancing drug discovery and promoting individualized medicine and regenerative medicine. The CQ3000’s capabilities are poised to streamline research processes, contributing to the development of new drugs and furthering our understanding of cutting-edge biology and medicine.